GEMS sees healthy order increase

Article

General Electric reported its first-quarter (end-March) fiscal results this month, breaking out for the first time profits in each of its business segments. The company’s technical products and services division, of which Waukesha, WI-based GE

General Electric reported its first-quarter (end-March) fiscal results this month, breaking out for the first time profits in each of its business segments. The company’s technical products and services division, of which Waukesha, WI-based GE Medical Systems is part, posted revenues of $1.5 billion for the quarter, a 34% increase over the previous year’s $1.1 billion. The division saw profits of approximately $268 million, up 15% from 1998’s $234 million.

GEMS reported a 42% increase in U.S. mammography orders for the quarter, which it attributed to the launch of herSource, an equipment, services, and financing program that supports women’s healthcare. CT orders climbed 25% worldwide during the period due to strong demand for GEMS’ LightSpeed QX/i system, the company said.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.